Microstructural brain changes in acromegaly: quantitative analysis by diffusion tensor imaging. 2014

R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
1 Department of Radiology, Bezmialem Vakif University School of Medicine, Istanbul, Turkey.

OBJECTIVE We examined brain diffusion changes of patients with acromegaly. We searched whether there are differences in apparent diffusion coefficient (ADC) and fractional anisotropy (FA) values between remission and non-remission patients with acromegaly and investigated any effect of time of hormone exposure on diffusion metrics. METHODS The values of FA and ADC were calculated in a total of 35 patients with acromegaly and 28 control subjects. Patients were subdivided into remission and non-remission groups. We looked at brain FA and ADC differences among the groups and looked for any relation between the diffusion changes and time of hormone exposure among the patients with acromegaly. RESULTS We found decreased FA and increased ADC values in some of the growth hormone responsive areas. There were no significant brain diffusion changes between remission and non-remission groups. The most affected areas were the hypothalamus, parietal white matter and pre-motor cortex in patients with acromegaly. In terms of hormone exposure time among the patients with acromegaly, there was no effect of disease duration on brain microstructural changes. CONCLUSIONS All patients with acromegaly showed increased brain diffusion with no relation to disease duration and treatment status. We suggested that in patients with acromegaly, brain damage had already occurred in the subclinical period before symptom onset. CONCLUSIONS This study contributes to the understanding of the mechanisms in acromegaly.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016880 Anisotropy A physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions. Anisotropies
D056324 Diffusion Tensor Imaging The use of diffusion ANISOTROPY data from diffusion magnetic resonance imaging results to construct images based on the direction of the faster diffusing molecules. Diffusion Tractography,DTI MRI,Diffusion Tensor MRI,Diffusion Tensor Magnetic Resonance Imaging,Diffusion Tensor MRIs,Imaging, Diffusion Tensor,MRI, Diffusion Tensor,Tractography, Diffusion

Related Publications

R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
January 2017, Journal of neuroimaging : official journal of the American Society of Neuroimaging,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
December 2015, Acta neurologica Belgica,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
January 2014, PloS one,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
November 2006, Pediatric radiology,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
September 2021, Social cognitive and affective neuroscience,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
August 2009, Bipolar disorders,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
January 2020, Neuro-degenerative diseases,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
October 2021, Alzheimer's research & therapy,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
February 2013, The American journal of gastroenterology,
R Kilicarslan, and M M Ilhan, and A Alkan, and A Aralasmak, and M E Akkoyunlu, and L Kart, and E Tasan
August 2009, Neurology,
Copied contents to your clipboard!